Advertisement
Advertisement

CGEM

CGEM logo

Cullinan Therapeutics, Inc. Common Stock

17.73
USD
Sponsored
-0.22
-1.23%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

17.40

-0.33
-1.86%

Cullinan Therapeutics, Inc. Common Stock Profile

About

Cullinan Therapeutics Inc. is a biopharmaceutical company focused on developing modality-agnostic targeted therapies. The company's product pipeline consists CLN-978. Cullinan Therapeutics Inc., formerly known as Cullinan Oncology Inc., is based in CAMBRIDGE, Mass.

Info & Links

CEO

Nadim Ahmed

Headquarters

ONE MAIN STREET, SUITE 1350
CAMBRIDGE, MA 02142, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.cullinanoncology.com

Auditor

KPMG LLP

Share holders

9

Employees

109

Cullinan Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.12B

Enterprise Value

1.04B

Enterprise Value/EBITDA(ttm)

-4.70

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.98

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-50.08%

Return on Invested Capital(ttm)

-53.87%

Return on Assets(ttm)

-45.98%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-221.49M

Net Income Available to Common(ttm)

-204.69M

Diluted EPS(ttm)

-3.10

Share Statistics

Beta (5Y Monthly)

0.01

52-Week Change

152.20%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

64.35M

Dividend Yield

0.00%

Float4

56.17M

% Held by Insiders

8.60%

% Held by Institutions

86.31%

Balance Sheet

Total Cash(mrq)

334.54M

Total Cash Per Share(mrq)

5.20

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

8.42%

Quick Ratio(mrq)

10.28%

Book Value Per Share(mrq)

5.00

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.37

Free Cash Flow(ytd)

-84.26M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement